Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Re-engineering of pathogenic aquaporin 4-specific antibodies as molecular decoys to treat neuromyelitis optica.
Effects of functional electrical stimulation on gait function and quality of life for people with multiple sclerosis taking dalfampridine.
Studies of EN-1639A (naltrexone): a new narcotic antagonist.
Plasma chemerin levels in patients with multiple sclerosis.
Structure of the first sphingosine 1-phosphate receptor.
Increase in the prevalence of multiple sclerosis over a 17-year period in Osona, Catalonia, Spain.
Safety and Tolerability Study of MEDI-551, a B-cell Depleting Agent, to Treat Relapsing Forms of Multiple Sclerosis
Therapeutic efficacy of IL-17 neutralization in murine experimental autoimmune encephalomyelitis.
Multiple sclerosis risk loci and disease severity in 7,125 individuals from 10 studies.
Tapered withdrawal of phenytoin removes protective effect in EAE without inflammatory rebound and mortality.
Iron and Non-Iron-Related Characteristics of Multiple Sclerosis and Neuromyelitis Optica Lesions at 7T MRI.
Are there Epstein-Barr virus seronegative patients with multiple sclerosis?
The genetic and environmental bases of complex human-disease: extending the utility of twin-studies.
Polyunsaturated fatty acids in multiple sclerosis therapy.
Preventive healthcare use among males with multiple sclerosis.
Interleukin-1β alters glutamate transmission at purkinje cell synapses in a mouse model of multiple sclerosis.
Fine-tuning the central nervous system: microglial modelling of cells and synapses.
Transplantation of umbilical cord and bone marrow-derived mesenchymal stem cells in a patient with relapsing-remitting multiple sclerosis.
Added benefit of fampridine is not proven
FTY720 (Fingolimod) Attenuates Beta-amyloid Peptide (Aβ(42))-Induced Impairment of Spatial Learning and Memory in Rats.
[Side-effects of glucocorticosteroids in multiple sclerosis: a case report of a patient with global amnesia.]
The role of growth factors as a therapeutic approach to demyelinating disease.
Heat shock protein 27 in multiple sclerosis relapses.
Revisiting The Multiple Sclerosis Functional Composite: proceedings from the National Multiple Sclerosis Society (NMSS) Task Force on Clinical Disability Measures.
A Novel MicroRNA-132-Surtuin-1 Axis Underlies Aberrant B-cell Cytokine Regulation in Patients with Relapsing-Remitting Multiple Sclerosis.
Pages
« first
‹ previous
…
146
147
148
149
150
151
152
153
154
…
next ›
last »